Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

Similar articles for PubMed (Select 21109222)

1.

Population differences in the rate of proliferation of international HapMap cell lines.

Stark AL, Zhang W, Zhou T, O'Donnell PH, Beiswanger CM, Huang RS, Cox NJ, Dolan ME.

Am J Hum Genet. 2010 Dec 10;87(6):829-33. doi: 10.1016/j.ajhg.2010.10.018. Epub 2010 Nov 25.

2.

[A cross-racial analysis on the susceptible gene polymorphisms of salt-sensitive hypertension].

Lu JP, Zhang L, Wang W.

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Oct;38(10):943-8. Chinese.

PMID:
21176642
4.
5.

Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

Mitra AK, Crews KR, Pounds S, Cao X, Feldberg T, Ghodke Y, Gandhi V, Plunkett W, Dolan ME, Hartford C, Raimondi S, Campana D, Downing J, Rubnitz JE, Ribeiro RC, Lamba JK.

J Pharmacol Exp Ther. 2011 Oct;339(1):9-23. doi: 10.1124/jpet.111.182873. Epub 2011 Jun 28.

6.

Geographical affinities of the HapMap samples.

He M, Gitschier J, Zerjal T, de Knijff P, Tyler-Smith C, Xue Y.

PLoS One. 2009;4(3):e4684. doi: 10.1371/journal.pone.0004684. Epub 2009 Mar 4.

7.

Evaluating the performance of commercial whole-genome marker sets for capturing common genetic variation.

M├Ągi R, Pfeufer A, Nelis M, Montpetit A, Metspalu A, Remm M.

BMC Genomics. 2007 Jun 11;8:159.

8.
9.

Population differences in microRNA expression and biological implications.

Huang RS, Gamazon ER, Ziliak D, Wen Y, Im HK, Zhang W, Wing C, Duan S, Bleibel WK, Cox NJ, Dolan ME.

RNA Biol. 2011 Jul-Aug;8(4):692-701. doi: 10.4161/rna.8.4.16029. Epub 2011 Jul 1.

10.

Practical considerations for imputation of untyped markers in admixed populations.

Shriner D, Adeyemo A, Chen G, Rotimi CN.

Genet Epidemiol. 2010 Apr;34(3):258-65. doi: 10.1002/gepi.20457.

11.

Tag SNP selection for Finnish individuals based on the CEPH Utah HapMap database.

Willer CJ, Scott LJ, Bonnycastle LL, Jackson AU, Chines P, Pruim R, Bark CW, Tsai YY, Pugh EW, Doheny KF, Kinnunen L, Mohlke KL, Valle TT, Bergman RN, Tuomilehto J, Collins FS, Boehnke M.

Genet Epidemiol. 2006 Feb;30(2):180-90.

PMID:
16374835
12.

Comprehensive evaluation of imputation performance in African Americans.

Chanda P, Yuhki N, Li M, Bader JS, Hartz A, Boerwinkle E, Kao WH, Arking DE.

J Hum Genet. 2012 Jul;57(7):411-21. doi: 10.1038/jhg.2012.43. Epub 2012 May 31.

13.

Inference of unexpected genetic relatedness among individuals in HapMap Phase III.

Pemberton TJ, Wang C, Li JZ, Rosenberg NA.

Am J Hum Genet. 2010 Oct 8;87(4):457-64. doi: 10.1016/j.ajhg.2010.08.014.

14.
15.

Recent human effective population size estimated from linkage disequilibrium.

Tenesa A, Navarro P, Hayes BJ, Duffy DL, Clarke GM, Goddard ME, Visscher PM.

Genome Res. 2007 Apr;17(4):520-6. Epub 2007 Mar 9.

16.
17.

On the challenges of the HapMap resource.

Zhang W, Dolan ME.

Bioinformation. 2008 Jan 11;2(6):238-9.

18.

The HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics.

Zhang W, Ratain MJ, Dolan ME.

Bioinform Biol Insights. 2008;2:15-23. Epub 2008 Feb 1.

19.

Mixed effects modeling of proliferation rates in cell-based models: consequence for pharmacogenomics and cancer.

Im HK, Gamazon ER, Stark AL, Huang RS, Cox NJ, Dolan ME.

PLoS Genet. 2012 Feb;8(2):e1002525. doi: 10.1371/journal.pgen.1002525. Epub 2012 Feb 9.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk